Our assessment
Genesis prices one product across three commitment lengths and prints the billed total beside each, and the arithmetic checks out — more than most sellers manage. Against it: only semaglutide is priced although the site title names both drugs, the product copy on a semaglutide page describes a dual-agonist mechanism that semaglutide does not have, and the company carries an FDA warning letter over how it described these products.
Three terms, three totals
The product page prices a monthly plan, a quarterly plan and an annual plan, and prints the amount billed for each alongside the per-month figure. Divide the quarterly total by three and the annual total by twelve and both give the printed rates.
The annual plan carries the lowest figure on the page, and it is easy to scroll past. Check all three before you pick one.
One drug priced, two named
The site title names semaglutide and tirzepatide. The product page prices semaglutide alone. Nothing on it prices a tirzepatide product.
The same page describes what it is selling as access to a dual GLP-1 and GIP mechanism. Semaglutide is a single-agonist molecule; the dual mechanism belongs to tirzepatide. That is either boilerplate carried across from another product page or a claim that isn't true of the product, and the page doesn't resolve which.
Either way, confirm which molecule you are buying before you order.
The warning letter
FDA wrote to this company in February 2026, having reviewed the website in December 2025, and found its claims about compounded semaglutide and tirzepatide false or misleading under the misbranding provisions of the Act.
Eighty of the four hundred and twenty sellers here carry a warning letter. It is disclosed and it moves nothing. The letter is filed under the company's legal name rather than the brand, so a search on the brand won't find it.
No compounding pharmacy is named and no individual clinician is named. No service area is published. The membership question goes unanswered on a page carrying three plan prices.
Genesis Health's published pricing
Prices re-verified September 2026
| Medication | Price |
|---|---|
| MedicationSemaglutide (compounded) — annual plan | Price$91.67/moper month on the annual plan, billed $1,100 once a year |
| MedicationSemaglutide (compounded) — quarterly plan | Price$116.67/moper month on the quarterly plan, billed $350 every three months |
| MedicationSemaglutide (compounded) — monthly plan | Price$175/moper month on the month-to-month plan, billed monthly |
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
See Genesis Health's current price →Who Genesis Health suits
Good fit if
- Readers who want three commitment lengths priced with their totals for one product.
- Buyers who want to see stock status stated on a product page rather than discovered at checkout.
Look elsewhere if
- Anyone shopping for tirzepatide. It is named in the site title and not priced on the page.
- Readers for whom an FDA warning letter about website claims is disqualifying.
- Buyers who want the compounding pharmacy or a clinician named, or a service-area list.
- People who need the membership question answered.
What stands out about Genesis Health
Strengths
- Prices three plan terms for one product and prints the billed total for each, and the quarterly and annual totals divide to the printed per-month figures
- Marks the product in stock on the page rather than leaving availability unstated
- States each batch undergoes quality checks and describes what the plan includes
- The operating company is named at the top of the privacy policy and in its footer
Trade-offs
- Received an FDA warning letter (No. 721451, issued 20 February 2026) finding claims about its compounded semaglutide and tirzepatide false or misleading
- Only the semaglutide product is priced on the page read; the tirzepatide named in the site title is not
- Names no compounding pharmacy and no individual prescribing clinician
- Publishes no service-area list
- Its own product copy describes access to a dual GLP-1 and GIP mechanism on a page selling semaglutide, which is a single-agonist molecule
How this review was verified
- The compounded semaglutide product page and the privacy policy were read.
- All three plan terms are published with their totals, and each total divides to its printed per-month figure.
- The site title names both molecules. Only semaglutide has a priced product page.
- The semaglutide page describes a dual GLP-1 and GIP mechanism, which belongs to tirzepatide. Nothing on the page reconciles that.
- Checked the FDA's public warning-letter database: a February 2026 letter to the operating company about claims made on this website. It is filed under the legal entity, not the brand.
Where Genesis Health ranks
Genesis Health qualifies for 2 of the 6 boards on this site. A board only ranks the providers that meet its own condition, so a missing board means Genesis Health does not publish what that board sorts on.
- Semaglutide — #231 of 334
- Cheapest Overall — #263 of 396
Compare Genesis Health directly
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
| Provider | Score | From/mo | Full review | Action |
|---|---|---|---|---|
| Belle Health | 10.0/10 | From/mo$109Advertised monthly equivalent for a twelve-month supply; not a verified monthly installment. Six-month rate $119, two-month rate $135, one-month rate $199. Confirm the upfront payment and refill schedule. | Full reviewRead the Belle Health review | Visit |
| Midi Health | 10.0/10 | From/mo$164for a 4-week supply, the lowest of four published dose tiers, including shipping | Full reviewRead the Midi Health review | Visit |
| altRx | 8.6/10 | From/mo$89/moadvertised monthly starting price for a multi-dose vial; confirm plan length and checkout total | Full reviewRead the altRx review | Visit |
Frequently asked questions
Is tirzepatide priced?
No. The site title names both drugs; only semaglutide has plan prices.
Do the plan totals add up?
Yes. The quarterly total divides by three and the annual total by twelve to the printed per-month figures.
Why does a semaglutide page describe a dual mechanism?
Semaglutide is a single-agonist molecule and the dual GLP-1 and GIP mechanism belongs to tirzepatide. Nothing on the page reconciles the two, so confirm which molecule you are buying.
What does the FDA warning letter say?
That FDA reviewed the website in December 2025 and found the claims made there about compounded semaglutide and tirzepatide false or misleading. It concerns website claims and does not move this seller's score or position here.
Is there a membership fee?
Not stated, on a page carrying three plan prices.
Ready to compare directly?
Genesis Health scores 2.9/10 on this site's rubric. Review the published prices and their conditions above, then confirm your total with the provider. Visiting its site does not commit you to treatment.
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
Visit Genesis Health →